Halozyme Therapeutics (HALO)

Common Shares
Sell: $67.00|Buy: $68.05|Change: 0.74 (1.10%)

Cash flow

Operating cash flow
Taxation
Investing activities
Financing
Foreign exchange adjustments
Opening balance